Gainesville, FL, United States of America

Hamad Yadikar

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hamad Yadikar: Innovator in Tauopathy-Related Neurodegenerative Disorders

Introduction

Hamad Yadikar is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of neurodegenerative disorders, particularly through his innovative work on DNA aptamers that target tau proteins. His research aims to address the challenges posed by tauopathy-related conditions.

Latest Patents

Hamad Yadikar holds a patent for "Tau protein-binding DNA aptamers with capture/detection and therapeutic utilities in tauopathy-related neurodegenerative disorders." This patent identifies DNA aptamers that bind to tau protein at its phosphorylatable sites. These aptamers not only recognize tau at specific sites but also exhibit inhibitory effects on tau protein phosphorylation and oligomer formation. The molecular probes derived from these DNA aptamers can be utilized as capture or detection agents to measure tau and phosphor-tau levels in cerebrospinal fluid. Additionally, they can be employed for cell-based or in vivo brain imaging in live animals or humans. The compositions containing these DNA aptamers have the potential to halt or treat the progression of tauopathy associated with neurodegenerative disorders.

Career Highlights

Throughout his career, Hamad Yadikar has worked with esteemed organizations, including the University of Florida Research Foundation and the United States Government as represented by the Department of Veterans Affairs. His work has been instrumental in advancing research in neurodegenerative diseases.

Collaborations

Hamad has collaborated with notable colleagues such as Ka W Wang and Weihong Tan, contributing to the advancement of research in his field.

Conclusion

Hamad Yadikar's innovative work in developing DNA aptamers for tau protein detection and therapeutic applications marks a significant advancement in the fight against tauopathy-related neurodegenerative disorders. His contributions continue to pave the way for future research and potential treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…